Life Sciences

The need for alignment to achieve health outcomes for all

As populations age and chronic diseases become commonplace, health care will take an ever larger share of GDP. Scientific progress, augmented intelligence and a more empowered patient are driving changes in the delivery of health care to a personalized experience that demands health outcomes as the core metric. This is causing a power shift among traditional stakeholder groups, with new entrants (often not driven by profit) disrupting incumbents.

Innovation, productivity and access to patients remain the industry’s biggest challenges. These trends challenge the capital strategy of every link in the life sciences value chain, from R&D and product supply to product launch and patient-centric operating models.

Our Global Life Sciences Sector brings together a worldwide network of 11,000 sector-focused professionals to anticipate trends, identify their implications and help our clients create competitive advantage. We can help you navigate your way forward and achieve sustainable success in the new health-outcomes-driven ecosystem.

Contact us

EY - Aidan Meagher

Aidan Meagher
Head of Life Sciences
International Tax Services
 +353 (1) 221 1139
linkedIn Aidan Meagher Aidan Meagher


EY - Graham Reid

Graham Reid
Corporate Finance
Head of Transaction Advisory Services
 +353 1 221 1449


EY - Feargal De Freine

Feargal De Freine
Assurance Partner
 +353 1 221 1636


Connect with us

Stay connected with us through social media, email alerts or webcasts. Or download our EY Insights app for mobile devices.

EY - Optimise for today? Build for tomorrow?

Optimise for today? Build for tomorrow?

Whether you’re transforming your business today, or transform the sector tomorrow. EY can help you do both better.

EY - Ireland Life Sciences

Ireland Life Sciences

EY discusses the Life Sciences sector